The quarter slightly beat the published EPS bar, but the guidance raise is the bigger signal. Diluted EPS was $0.51 versus a published consensus of roughly $0.49-$0.50, a narrow beat rather than a major earnings surprise. Revenue reached $4.58 billion, while Adjusted EBITDA was $2.49 billion; no reliable published consensus was available for those metrics. (Income Statement) (Adjusted EBITDA reconciliation)
| Metric | Q2 2026 | Q2 2025 | Change | Market reference |
|---|---|---|---|---|
| Revenue | $4.578B | $3.101B | +48% | No reliable published consensus |
| Income from operations | $2.188B | $1.038B | +111% | No reliable published consensus |
| Net income attributable to common stockholders | $1.347B | $0.368B | +266% | — |
| Diluted EPS | $0.51 | $0.14 | +264% | Consensus ~$0.49-$0.50 |
| Consolidated Adjusted EBITDA | $2.491B | $1.393B | +79% | No reliable published consensus |
| LNG volumes sold | 466.4 TBtu | 329.2 TBtu | +42% | — |
| 2026 Adjusted EBITDA guidance | $8.7B-$9.1B | Prior: $8.2B-$8.5B | Midpoint +6.6% | — |
Management raised full-year EBITDA guidance meaningfully, moving the result beyond merely in line. The new $8.7-$9.1 billion range lifts the midpoint by about $550 million from the prior $8.35 billion midpoint. That is the clearest expectation-positive change in the filing, supported by stronger production, higher implied liquefaction fees on remaining unsold cargoes, and more than $100 million of annual refinancing savings. (Guidance) (Management commentary)
The earnings growth is being driven by commissioning volumes and pricing, not yet a fully normalized operating base. LNG volumes sold rose 42% year over year, with management attributing much of the increase to Plaquemines commissioning progress and higher sales prices net of feed-gas costs under commissioning agreements. That supports near-term cash generation, but commissioning economics may not be representative of post-COD margins. (Financial Highlights) (Management commentary)
Plaquemines remains the central execution catalyst, and the filing removes no timing from the prior plan. Phase 1 COD is still targeted for the fourth quarter of 2026, Phase 2 for mid-2027, and CP2 first LNG for the second half of 2027. Because those dates were reaffirmed rather than accelerated, the update is supportive but not a new schedule upside surprise. (Plaquemines) (CP2)
The stronger outlook comes with a heavier balance sheet. Long-term debt rose to $41.5 billion from $33.4 billion at December 31, 2025, even as cash increased to $3.1 billion. The refinancing savings are helpful, but the filing still describes a highly capital-intensive, leveraged expansion story; the guidance upgrade improves the earnings picture without removing financing and execution risk. (Balance Sheets) (Management commentary)
Net read: moderately positive versus expectations. The quarter itself was only a narrow EPS beat, but the 2026 EBITDA guidance increase and continued Plaquemines/CP2 execution provide a broader upside revision to the market's standing assumption.
Read the original 8-K on SEC EDGAR ↗